PATENT CLAIM ANALYSIS

Application Number: 16375773
Application Type: Utility
Filing Date: 2019-04
Publication Date: 2019-08
Patent Classification: ["514", "233200"]

Abstract:
This invention generally relates to substituted imidazopyridine compounds, particularly substituted 4-(imidazo[1,2-a]pyridin-2-yl)benzamide compounds and salts thereof. This invention also relates to pharmaceutical compositions and kits comprising such a compound, uses of such a compound (including, for example, treatment methods and medicament preparations), processes for making such a compound, and intermediates used in such processes.

Claim (Index 1):
A method for treating a disorder associated with P2X3 activity in an animal, wherein the disorder associated with P2X3 activity is selected from the group consisting of multiple sclerosis, Parkinson's disease, Huntington's chorea, Alzheimer's disease, endometriosis, depression, anxiety, a stress-related disorder, and drug addiction, and wherein the method comprises administering to the animal a therapeutically effective amount of a pharmaceutically active compound of Formula (I) or a salt thereof, wherein the compound of Formula (I) is: R 1  is selected from the group consisting of cyano, halogen, methyl, and ethyl; R 2  is selected from the group consisting of hydrogen, halogen, methyl, and ethyl; R 3  is selected from the group consisting of halogen, methyl, and ethyl; R 4  is selected from the group consisting of hydrogen, halogen, methyl, ethyl, and methoxy; as to R 5  and R 6 ; R 5  and R 6  are independently selected from the group consisting of hydrogen, C 1 -C 6 -alkyl, and hydroxy-C 1 -C 6 -alkyl; or R 5  and R 6 , together with the nitrogen to which they are both attached, form a 5- or 6-member heterocycloalkyl, wherein: the heterocycloalkyl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, hydroxyl, and C 1 -C 4 -alkyl; R 7  and R 8  are independently selected from the group consisting of hydrogen and C 1 -C 4 -alkyl; R 9  is selected from the group consisting of C 1 -C 6 -alkyl, C 3 -C 6 -cycloalkyl, C 1 -C 6 -alkyl-C 3 -C 6 -cycloalkyl, halo-C 1 -C 6 -alkyl, C 1 -C 6 -alkoxy, halo-C 1 -C 6 -alkoxy, and C 1 -C 6 -alkoxy-C 1 -C 6 -alkyl; and X is selected from a bond, CH 2 , and O.

Metadata:
- Claim Count in Document: 56.0
- Percentile: 100.0
- Lexical Diversity: 1.57778
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15423428', '15716410', '14764404', '13472825', '15820429']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8154797751972512
- 35 USC 102 Novelty (BERT): 0.5210024438986665
- Combined Prediction Score: 0.7860320420673927
- Mean Citation Score: 295.54550000000006
- Max Citation Score: 339.7396
- Similarity Product: 293.5935446821452

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test